NCT02304224

Brief Summary

The aim of the study is to investigate the relationship of nocturnal use of eye masks and immune function, cerebral function and outcomes of patients with sepsis. Thus more efficient and comprehensive treatment could be provided for patients in the duration of admission in intensive care unit.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P25-P50 for not_applicable sepsis

Timeline
Completed

Started Dec 2014

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 24, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 1, 2014

Completed
Same day until next milestone

Study Start

First participant enrolled

December 1, 2014

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2016

Completed
Last Updated

December 1, 2014

Status Verified

November 1, 2014

Enrollment Period

1 year

First QC Date

November 24, 2014

Last Update Submit

November 25, 2014

Conditions

Keywords

sepsismelatoninHuman Leukocyte Antigen-DRoutcome

Outcome Measures

Primary Outcomes (1)

  • survival of participants

    up to 28 days after hospitalization

Secondary Outcomes (4)

  • Cerebral Performance Category(CPC) of Participants

    up to 7 days after hospitalization

  • Cerebral Performance Category(CPC) of Participants

    up to 28 days after hospitalization

  • Glasgow Coma Scale (GCS) of Participants

    up to 7 days after hospitalization

  • Glasgow Coma Scale (GCS) of Participants

    up to 28 days after hospitalization

Study Arms (2)

Control

NO INTERVENTION

the patients with sepsis admitted in the intensive care unit aren't applied with eye masks at night

Eye masks

EXPERIMENTAL

the patients with sepsis in the intensive care unit are applied with eye masks at night in the duration of admission

Other: eye masks

Interventions

eye masks from 21:00 to 6:00 each night during admission

Eye masks

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Transferred into ICU before 21:00 the same day;
  • Consistent with the diagnosis of sepsis;
  • Written informed consent was obtained from patients or their family members.

You may not qualify if:

  • Age \< 18 years;
  • With sleep disorders; mental illness; cancer; autoimmune diseases; dysfunction of liver or kidney;
  • History of using of immune-related drugs; melatonin receptor agonist or antagonist; sleep-aid or mental- related drugs;
  • History of accepting radiotherapy or chemotherapy;
  • Doing shift work before admission.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Tenth Hospital

Shanghai, 200000, China

Location

MeSH Terms

Conditions

SepsisSleep Deprivation

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsDyssomniasSleep Wake DisordersNervous System DiseasesNeurologic ManifestationsSigns and SymptomsMental Disorders

Study Officials

  • Yuanzhuo Chen, M.D.

    Shanghai 10th People's Hospital

    STUDY CHAIR
  • Wenjie Li, M.D.

    Shanghai 10th People's Hospital

    PRINCIPAL INVESTIGATOR
  • Huiqi Wang, M.D.

    Shanghai 10th People's Hospital

    PRINCIPAL INVESTIGATOR
  • Chengjin Gao, M.D.

    Shanghai 10th People's Hospital

    STUDY DIRECTOR
  • Hu Peng, M.D.

    Shanghai 10th People's Hospital

    STUDY DIRECTOR
  • Yugang Zhuang, M.D.

    Shanghai 10th People's Hospital

    PRINCIPAL INVESTIGATOR
  • Xiangyu Zhang, M.D.

    Shanghai 10th People's Hospital

    STUDY DIRECTOR

Central Study Contacts

Wenjie Li, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

November 24, 2014

First Posted

December 1, 2014

Study Start

December 1, 2014

Primary Completion

December 1, 2015

Study Completion

February 1, 2016

Last Updated

December 1, 2014

Record last verified: 2014-11

Locations